Deseret Mutual Benefit Administrators Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Deseret Mutual Benefit Administrators raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,029 shares of the healthcare conglomerate’s stock after buying an additional 27 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in UnitedHealth Group were worth $521,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. DecisionPoint Financial LLC raised its holdings in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group during the third quarter worth about $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 7.3 %

Shares of NYSE:UNH opened at $465.58 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market cap of $428.46 billion, a price-to-earnings ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The firm’s 50 day moving average price is $519.27 and its 200 day moving average price is $560.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.83 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.